Emulgel: Magnifying the application of topical drug delivery by Sah, Shailendra Kumar et al.
*Corresponding Author: Shailendra Kumar Sah, Department of Pharmaceutics, Division of PharmaceuticalSciences, Shri Guru Ram Rai Institute 
of technology and Sciences, Patel Nagar, Dehradun, UK, India. E-Mail: sahshailendra31@gmail.com                                                                        25                                                                                                                              
    
 
Indian J. Pharm. Biol. Res. 2017; 5(1):25-33
                                                          
 
Review Article 
Emulgel: Magnifying the application of topical drug delivery  
Shailendra Kumar Sah*, Ashutosh Badola, Bipin Kumar Nayak 
Department of Pharmaceutics , Division of pharmaceutical sciences, Shri Guru Ram Rai Institute of Technology and Sciences, 
Patel Nagar Dehradun, Uttarakhand, India 
 
ARTICLE INFO: 
Article history: 
Received: 18 January 2017 
Received in revised form: 
28 January 2017 
Accepted: 30 January 2017 
Available online: 30March 2017 
Keywords: 
Emulgel, 
Topical drug delivery, 
Gelling agent,  
Emulsifying agent,  
Drug entry through skin.  
 
 
 
 
 
 
 
 
 
 
ABSTRACT 
Topical drug delivery is mostly culled for the local dermatological action, but recently the 
new technologies are also enhancing its systemic effect. They are generally applied for the 
purpose as antiseptics, antifungal agents, skin emollients, and protectants. The activity of 
topical preparation confide in the various factors as drug solubility, its lipophilicity, contact 
time to skin, its permeability. Many widely used topical agents like ointments, creams, 
lotions, gel are associated with disadvantages like stability problems, stickiness and lesser 
spreading coefficient, irritation, allergic reactions, poor permeability, poor absorption and 
difficulty in absorption of large molecule, to rectify this the new concept of Emulgel has been 
introduced with the main objective to deliver hydrophobic drug molecule. Emulgel is oil in 
water or water in oil emulsion carrying drug to be incorporated in gel base to obtain gellified 
emulsion. Emulgel shows the controlled and better release effect of drug by virtue of 
combined effect of gel and emulsion with increased stability.  Gel having various advantages 
as non greasy & favors good patient compliance in field of cosmetology and dermatology but 
are still limited to the deliver hydrophobic drugs. So the Emulgel comes to favour the 
hydrophobic drugs to give the advantages of gel. Emulgels have several advantages in the 
field of dermatology such as being thixotropic, greaseless, easily spreadable, easily 
removable, emollient, nonstaining, long shelf life, bio-friendly, transparent and pleasing 
appearance. Factors such as gelling agent, oil agent, emulsifiers influence the stability and 
efficacy of emulgel. So emulgels can be the better semisolid preparation than other 
conventional systems.  At present the emulgel are being used for the delivery of analgesics, 
anti-inflammatory, anti-fungal, anti-acne drugs and various cosmetic formulations with still 
wide range to explore. 
Introduction
Topical drug delivery having several years of history, still new 
technology and methods are investigated; as skin is most 
accessible organ and are potential to facilitate the delivery of 
several drugs with better efficacy than rest of any other route 
of administration. With the recent advancement in technology 
and knowledge it can deliver drug to the skin and also for 
systemic purpose. This route is one of the best option for the 
cutaneous purpose [1].Topical drug delivery is defined as the 
localized application of formulation in the body through 
ophthalmic, rectal, nasal, vaginal and skin with the approach 
to increase its bioavailability and reduction in side effects [2, 
3]. This delivery is preferred when other system fails or has 
some limitation and generally used for the skin fungal 
infection. Basically there is two type of topical products one is 
external topical that is spread to the tissue to cover the 
diseased area and other is internal topical that are applied for 
topical effect to mucous membrane in oral cavity, vagina, or 
rectal tissues [4]. Advantages for the topical drug delivery are 
as Patient compliance, Ease of administration, Improvement in 
drug bioavailability, better physiological and pharmacological 
response, Minimum systemic toxicity and exposure of drug to 
non-infectious tissue/sites, easy termination of the treatment, 
avoid hepatic first pass metabolism, avoid gastric 
incompatibilities, minimum fluctuation in plasma levels and 
suitable for the drug with narrow therapeutic window. Topical 
formulation must allow for optimal penetration of the drug 
into the skin (pH 5.5), a complex tissue thus the pH of the 
formulation may change following application to the skin, so 
          CODEN (USA): IJPB07                                                                     ISSN: 2320-9267   
                                                                    
Indian Journal of Pharmaceutical and Biological Research (IJPBR) 
Journal homepage: www.ijpbr.in 
Sah et al / Indian J. Pharm. Biol. Res., 2017; 5(1):25-33 
 
Review Article  26 
 
before formulating topical adequate knowledge about the 
nature and behavior of skin should  be reviewed. Challenges 
associated  with the development of topical drug delivery is 
selection of active principle and also the vehicle in which the 
drug is being delivered, since the availability of drug to site of 
action may be limited due to barriers associated with these 
routes. Stratum corneum the major barrier for the passage of 
foreign particle through skin. Most of the topical drugs applied 
to eye are washed out within the minutes. Vaginal 
formulations efficacy is lowered due to the short residence 
time and inadequate spreading over the tissues. Due to these 
limitations researcher are interested to develop the new 
approaches [5, 6]. Many widely used topical agents like 
ointments, creams, lotions, gel are associated with 
disadvantages like stability problems, stickiness and lesser 
spreading coefficient, irritation, allergic reactions, poor 
permeability, poor absorption and difficulty in absorption of 
large molecule [4,7]. Cream, ointments and gels are the 
semisolid formulations which are commonly used for local 
and regional skin disorders. Semisolids can change their 
shape, because of plastic behaviors, except gels having 
viscoelastic effect because of showing liquid and solid 
properties [8-10]. 
 
 
Classification of topical drug delivery systems [11] 
Solid  Semi solid  Liquid  Miscellaneous  
powders, 
Plasters 
Ointments, Creams, 
Poultices, Gels, Pastes 
Liniment, Lotions, solution, 
tinctures, Emulsions, 
Suspensions, Paints 
Transdermal drug delivery systems, 
Tapes and Gauzes, Rubbing alcohols, 
Liquid cleanser, Topical aerosol 
 
EMULGEL: Emulgel is emerging field for the topical drug 
delivery, and till date it has less marketed product, so it is 
interesting and challenging to focus on emulgel. Before going 
to emulgel we need to know the advantages of emulsion and 
gel that is being used for the topical drug delivery. Emulsions 
are controlled release systems containing two immiscible 
phase in which one is dispersed (internal or discontinuous 
phase) into other (external or discontinuous phase), with the 
use of emulsifying agent to stabilize the system. emulsion are 
of oil-in-water or water-in-oil type, where the drug particle 
entrapped  in internal phase passes through the external phase 
and then slowly gets absorbed into the skin to provide 
controlled  effect. USP defines gel as a semisolid system 
consisting of dispersions made up of either small inorganic 
particles or large organic molecules enclosing and 
interpenetrated by liquid. The gel contains the larger amount 
of aqueous or hydro alcoholic liquid in a cross linked network 
of colloidal solid particles where it captures small drug 
particles and maintain the controlled release of drug. The 
liquid phase builds a three-dimensional polymeric matrix 
which results a physical or chemical cross-linking. The 
continous structure results solid like behavior that are 
homogenous and clear. The emulsion and gel both are 
responsible for the controlled drug release from the systems 
[12-14]. The gels are of two types first the organic solvent 
based, hydrophobic or organogels and second the water based, 
hydrophilic or hydrogels. First one consist base liquid paraffin 
with polyethylene or fatty oils gelled with colloidal silica, 
aluminium or zinc soaps and the second one with the  base of 
water, glycerol, or propylene glycol[15,16]. gels having 
various advantages has still limitation in the delivery of 
hydrophobic drugs so to  overcome  this limitation and enjoy 
the delivery in the form of gel for the hydrophobic drug, the 
concept for emulgel was introduced where the hydrophobic 
drugs are incorporated in emulsion and then to gel[17]. 
Emulgel is the approach using the benefits of both emulsion 
and gels, gaining the dual controlled release effect where the 
emulsion either oil in water or water in oil is gelled by 
incorporation in the gel base [18], simply the Emulgels are 
emulsion in gel. In emulsion the drug particles are 
incorporated in the internal phase acting as drug reservoir 
from where the drug passes through the external phase and to 
the skin and get absorbed. Emulgel are seen better choice for 
the class II of drug as per the BCS classification systems that 
show poor solubility and high permeability [2]. Emulgel 
possess the properties as thixotropic, grease less, easily 
spreadable, easily removable, emollient, nonstaining, water 
soluble, long shelf life, biofriendly and pleasing appearance 
that improves the patient acceptability [4]. Emulgel are being 
used for the treatment of various anti-inflammatory activity 
and other skin related viral, bacterial and fungal infections [19, 
20].  
Advantages of emulgel [21-23] 
1. Increased patient acceptability.  
2. Provide targeted drug delivery. 
3. Easy termination of the therapy. 
4. Improve bioavailability and even the low doses can be 
effective in comparison with other conventional semi 
solid preparation. 
5. Stable formulation by decreasing surface interfacial 
tension resulting in increase in viscosity of aqueous 
phase, more stable than Transdermal preparations that 
are 
comparatively less stable, powders are hygroscopic, 
creams shows phase inversion or breaking and ointment 
shows rancidity due to oily base. 
6. Hydrophobic drug can be incorporated in emulgel using 
emulsion as the durg carrier that is finally dispersed in 
the gel.  
7. Provide the controlled effect of that enhance the 
prolong effect of the drug with short half life. 
8. Easy and cost effective preparation. 
9. Drug loading capacity is better than other novel 
approaches like niosomes and liposomes 
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10. Penetration to skin is enhanced due to both hydrophilic 
and hydrophobic nature. 
Disadvantages [2, 4] 
1. Poor absorption of macromolecules.   
2. Entrapment of bubble during formulation.  
3. Hydrophobic drugs are the best choice for such 
delivery systems. 
ANATOMY OF SKIN (BARRIER FOR TOPICAL DRUG 
DELIVERY) [24-27] 
Skin the dynamic and largest organ of the body with 16 % of 
body weight and surface area of 1.8m
2
. The pH of the skin 
varies from 4 to 5.6, Sweat and fatty acid secreted from sebum 
influence the pH of the skin surface. It is constantly changing 
by inner cells that replace the outer layer and are consistent 
throughout the body but varies in thickness according to site 
and age of the individual. Hair, nails, sebaceous, sweat and 
apocrine glands are regarded as derivatives of skin (Fig. 1).  
 
                                                                        Fig 1: The skin and its appendages [24] 
 
Epidermis the outer layer mainly composed of  keratinocytes 
and is typically 0.05–0.1 mm in thickness, serving as the 
physical and chemical barrier between the interior body and 
exterior environment.  Other cells in the epidermis are the 
melanocytes, Langerhans’ cells and Merkel cells. The four 
layers of the epidermis are:  
1. Stratum basale (basal or germinativum cell layer)  
The innermost layer of the epidermis consist mainly dividing 
and non-dividing keratinocytes, which are attached to the 
basement membrane by hemidesmosomes.  It also consists of 
melanocytes producing melanin pigment. Merkel cells are also 
found in the basal layer with large numbers in touchsensitive 
sites as the fingertips and lips. 
2. Stratum spinosum (spinous or prickle cell layer) 
Basal cells moves towards the outer layer as they reproduce 
and mature forming the stratum spinosum. Intercellular 
bridges, the desmosomes, which appear as `prickles' at a 
microscopic level, connect the cells. Langerhans cells are 
dendritic, immunologically active cells derived from the bone 
marrow, and are found on all epidermal surfaces but are 
mainly located in the middle of this layer having significant 
role in immune reactions of the skin, acting as 
antigen-presenting cells. 
3. Stratum granulosum (granular cell layer) 
Continuing their transition to the surface the cells continue to 
flatten, lose their nuclei and their cytoplasm appears granular 
at this level. 
4. Stratum corneum (horny layer)  
Result of keratinocyte maturation is found in the stratum 
corneum, made up of layers of hexagonal-shaped, non-viable 
cornified cells known as corneocytes. 10±30 layers of stacked 
corneocytes are found in most area of skin with maximum 
layer in palms and soles. Protein covers the corneocyte and is 
filled with water-retaining keratin proteins. Strength is gained 
due to cellular shape and orientation of the keratin proteins. 
Surrounding the cells in the extracellular space are lipid 
bilayers. The resulting structure provides the natural physical 
and water-retaining barrier of the skin. The corneocyte layer is 
capable to absorb water of about three times its weight but it 
cracks and no longer remains pliable if water content drops 
below 10%. 
Dermis 
Structural support and bulk of the skin is provided by the 
dermis the deeper layer and is responsible for pliability, 
elasticity, and tensile strength. It is an integrated system of 
fibrous, filamentous, and amorphous connective tissue that 
accommodates stimulus-induced entry by nerve and vascular 
networks, epidermally derived appendages, fibroblasts, 
macrophages, and mast cells. Blood-borne cells as 
lymphocytes, plasma cells, and other leukocytes, enter the 
dermis in response to various stimuli. It protects the body from 
mechanical injury, binds water, aids in thermal regulation, and 
includes receptors of sensory stimuli. The dermis interacts 
with the epidermis in maintaining the properties of both 
tissues. The two regions collaborate during development in the 
morphogenesis of the dermal-epidermal junction and 
epidermal appendages and interact in repairing and 
remodeling the skin as wounds are healed. Collagen a fibrous 
protein representing 70% of the skin’s dry weight is the main 
component of the dermis. 
Sah et al / Indian J. Pharm. Biol. Res., 2017; 5(1):25-33 
 
Review Article  28 
 
Subcutis 
 The subcutis or hypodermis is an important depot of fat and 
are made up of loose connective tissue and fat, which can be 
up to 3 cm thick on the abdomen. 
Skin Functions [24-27] 
Provide barrier to the environment that allows and limits the 
inward and outward passage of water, electrolytes and various 
substances while providing protection against micro-
organisms, ultraviolet radiation and toxic agents. Water loss 
from the skin is prevented by the cornified cell envelope and 
the stratum corneum while keratinocyte provide an innate 
immune defence against bacteria, viruses and fungi. 
Langerhans’ cells functions to survey the epidermal 
environment and to initiate an immune response against 
microbial threats, although they may also contribute to 
immune tolerance in the skin. Melanin provides protection 
against DNA damage from UV radiation. An important 
function of skin is thermoregulation. Vasodilatation or 
vasoconstriction of the blood vessels in the deep or superficial 
plexuses helps regulate heat loss. Eccrine sweat glands present 
in densities of 100–600/cm2; they play a role in heat control 
and produce approximately 1 litre of sweat per hour during 
moderate exercise. Secretions from apocrine sweat glands 
contribute to body odour (pheromones). Skin lubrication and 
waterproofing is provided by sebum secreted from sebaceous 
glands. Subcutaneous fat helps in cushioning trauma as well as 
providing insulation and a calorie reserve. Fat also has an 
endocrine function, releasing the hormone leptin, which acts 
on the hypothalamus to regulate hunger and energy 
metabolism. Other functions of fat cells include tissue 
remodelling and phagocytosis. Skin also has a key function in 
synthesizing various metabolic products, such as vitamin D of 
hemidesmosomal-anchoring filament complexes (more in the 
leg than the arm).  
FACTORS AFFECTING TOPICAL ABSORPTION OF 
DRUGS [28, 29] 
Physiochemical factors 
Drug substances 
1. Molecular weight (<400 dalton) 
2. Diffusion coefficient 
3. Water/lipid partition coefficient 
4.  Permeability coefficient 
5.  Ionization- unionized drug are well absorbed  
6. Protein binding  capacity. 
Vehicle  
7. Solubility/polarity 
8. Volatility 
9. Concentration 
10. Distribution in a stratum corneum 
11. Excipients 
12. Penetration enhancer 
13. PH 
 
 
Physiological Factors 
14. Skin thickness 
15. Lipid content 
16. Density of hair follicles 
17. Density of sweat glands 
18.  Skin pH 
19.  Blood flow 
20.  Hydration of skin 
21.  Inflammation of skin  
Site of application 
22. Skin area dose (film thickness, concentration) 
23. Total skin area in contact with vehicle 
24. Duration of exposure 
CONSIDERATION TAKEN IN ACCOUNT FOR THE 
TOPICAL DRUG DELIVERY SYSTEMS [30] 
Efficacy and penetration of active drug is enhanced by the 
proper selection of vehicle which may itself possess the 
cooling, drying, emollient of protective activity. Preparation 
should be matched with the type of lesions; For example, 
avoid greasy ointments for acute weepy dermatitis. Type of 
preparation should   be matched with the site of application. 
Irritation or sensitization potential should also be taken in 
consideration before selecting the type of topical preparation.  
 DRUG ENTRY THROUGH SKIN [31-34]  
Drug mostly penetrate the stratum corneum by passive 
diffusion whereas limited active transport follows these 
steps: drug dissolution in its vehicle than drug diffusion 
form the vehicle to surface of the skin and finally the 
actual penetration of the drug through the different layers 
of the skin. Active pass through the stratum corneum 
(lipophilic) into the viable epidermis and continue 
passively through to the dermis (hydrophilic) to the 
dermal-epidermal junction where the blood vessels carry it 
to the systemic circulation. Topical drugs are generally 
applied for three different functions. First, active for the 
surface of the skin e.g. for disinfection, insect repellents 
and cosmetics, so called epidermal formulations. Second 
functions when formulations are designed to penetrate into 
the deeper regions of the skin such as the viable epidermis 
and the dermis, so called endodermal or diadermal 
formulations. Thirdly, for the systemic action of drugs by 
transdermal application can be the aim of the topical 
therapy. Drug penetrates the stratum corneum by two 
options: the transepidermal route and the route via pores. 
The transepidermal route can be divided into the 
transcellular and the intercellular route. Transcellular route 
is the direct and the shortesh route where the drug directly 
passes through both the lipid structures of the stratum 
corneum and the cytoplasm of the dead keratinocytes, but 
encounter significant resistance to permeation because 
they have to cross both lipophilic and hydrophilic 
structures. Intercellular is the common route where the 
drug passes between the corneocytes. Since the skin 
appendages (glands and hair follicles) occupy only 0.1% 
of the total human skin surface, the contribution to the 
pore route was primarily considered to be small. However, 
for very lipophilic and large molecules (and some 
electrolytes) the appendages and other diffusion shunts 
may also play an important role. The follicular apparatus 
of hair follicles, the sweat glands and microlesions in the 
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interfollicular horny layer were introduced as theoretical 
vertical pathways for percutaneous penetration (Fig. 2). 
The lipophilic drug that easily crosses the stratrum 
corneum, show slow diffusion when it reaches the 
hydrophilic epidermis that causes the temporaray 
deposition, so called reservoir effect. Small molecular size 
Substances having both lipid and aqueous solubility are 
capable of best permeation effect. Electrolytes are difficult 
to absorb when they are applied in aqueous solutions 
because they create a field of stable hydration that 
increases the size of the diffusing component. The 
permeability coefficient of the drugs depends on the solute 
size, lipophilicity and the diffusion path length. Although 
Fick’s law describes that penetration depends on the 
thickness of the skin, later works show its dependency 
more on the lipid composition of the skin.  
 
 
Fig 2: pathways for drug entry 
 
CONSIDERATION ACCOUNTED AND INGREDIENTS 
USED IN THE FORMULATION OF EMULGEL. [2, 4, 
11] 
Aqueous material  
Make the aqueous phase in emulsion and for the swelling 
purpose of gelling agent. The most commonly used are water, 
alcohol etc 
Oil phase 
Selection is done by optimizing its effects on the viscosity, 
permeability, drug release, emulsification and stability for the 
preparation in oil phase of the emulsion, used for the solubility 
of hydrophobic drugs. It can also be selected as per the effect 
of active molecule that gives synergistic effect as various oils 
had medicinal value. The most commonly used oil phases are 
as mineral oils liquid paraffin, propylene glycol, isopropyl 
myristate, isopropyl palmitate, castor oil, olive oil, balsam oil, 
wool wax, soyabeen oil, cotton seed oil, oleic acid, maize oil, 
arachis oil etc  
Emulsifiers  
They are used for the emulsification and stability purpose of 
the product by decreasing the interfacial tension. Selection is 
done by proper hydrophilic and lipophilic balance (HLB) for 
example the surfactant with HLB value greater than 8 is used 
in oil in water emulsion where as the surfactant with HLB 
value less than 8 are used in water in oil emulsion. Tween are 
applicable for the water phase while the spans are applicable 
for the oil phase for emulsification. Mixture of tween and span 
provide better stability than single. eg Polyethylene glycol , 
Sorbitan monooleate (Span 80), Polyoxyethylene sorbitan 
monooleate (Tween 80), Stearic acid, labrasol, Sodium 
stearate etc 
Gelling agent  
Gelling agent may be of natural, synthetic source; selection of 
these polymers can be based on the multifunction as 
thickening and acting as emulsifying agents. They are 
incorporated to make the system thixotropic. Effect of gelling 
agent on the drug release pattern should be studied. Synthetic 
polymer is Carbopol. The cellulose derivatives form a 
colloidal solution. They disperse in water and because of 
acidic pH the solution have to neutralize by amines, e.g. 
triethanolamine or bases, e.g. sodium hydroxide. Depending 
on pH range Carbopol have different grades, e.g. Carbopol 
934, 940, etc. Natural materials such as tragacanth, carrageen, 
pectin, agar, xantham gum, alginic acid and starch; synthetic 
agents are: cellulose derivatives such as methylcellulose, 
hydroxyethylcellulose, hydroxypropylmethylcellulose, 
carboxyvinyl polymers, carboxymethylcellulose and 
magnesium aluminium silicates etc 
Permeation Enhancers 
 Agents that partition into, and interact with skin constituents 
to induce a temporary and reversible increase in skin 
permeability. For example, Oleic acid, Menthol, Clove oil, 
Lecithine, Isopropyl myristate, Urea, Linoleic acid, Cinnamon 
etc 
METHOD OF PREPARATION FOR EMULGEL [21, 30] 
It has very simple and cost effective method of preparation 
basically including three steps; first the preparation of oil in 
water or water in oil emulsion where the drug is incorporated 
as per our formulation requirement then second step is to 
formulate the gel base and finally the  addition of emulsion to 
gel in continuous stirring to form emulgel . in detail for the 
formulation of emulsion the aqueous phase is prepared by 
taking the purified water to which the  soluble ingredient are 
added and heated up to 70ºc including emulsifying agent as 
Sah et al / Indian J. Pharm. Biol. Res., 2017; 5(1):25-33 
 
Review Article  30 
 
tweens and then the oil phase are prepared by dissolving the 
surfactant such as spans also heated to same temperature with 
the addition of hydrophobic drug. The gel phase is prepared by 
dispersing the polymer in purified water with constant stirring 
at a moderate speed and then the pH are adjusted to 6 to 6.5 as 
per the requirement of the polymer. For example pH of gel 
with carbopol is adjusted by Tri ethanol amine (TEA). 
Preservatives were mixed with the aqueous phase. Both the 
oily and aqueous phases were separately heated to 70° to 
80°C; then the oily phase were added to the aqueous phase 
with continuous stirring until cooled to room temperature. 
Now the emulsion is added to the gel base in ratio 1:1 to 
obtain the emulgel.  
EVALUATION OF EMULGEL 
Physical appearance [35]  
The prepared formulations were inspected visually for their 
colour,homogeneity,consistency. 
pH [35] 
One gram of gel was dissolved in 100ml distilled water and 
stored for two hours and pH measured with digital pH meter. 
pH values should be in range of 5 to 6 similar to the skin pH 
5.5 that avoid the risk of irritation   
Spreadability [8,35]  
Spreading coefficient was measured on the basis of ‘Slip’ and 
‘Drag’ characteristics of emulgels. One gram of emulgel was 
placed between the two glass slides and load of 500 g was 
applied for 5 min to expel air and to provide a uniform film of 
the emulgel between the two slides. Second glass slide is 
provided with the hook. Measured quantity of weight was 
placed in the pan attached to the pulley with the help of hook.  
The time required to slip off the slides 
was measured.  
 
Lesser the time taken for separation of two slides, better the 
spreadability. Spreadability was calculated using formula 
S = M. L / T 
Where M = wt. tied to upper slide 
L = length of glass slides 
T = time taken to separate the slides. 
Extrudability[35] 
Here the weight required to extrude 0.5 cm ribbon of emulgel 
in 10 sec from lacquered collapsible aluminum tube is 
determined. Test was repeated and the average values were 
used for the calculation. 
Formula for extrudability calculation 
Extrudability = weight applied to extrude emulgel from tube 
(gm)/Area (cm²) 
Viscosity [12] 
Viscosity Determined by using a cone and plate type of 
Brookfield viscometer (Brookfield viscometer RVT) with 
spindle No.7. The maximum shear rate was 100 RPM while 
minimum shear rate was 10 RPM. 
Swelling Index [36] 
Formulation with maximum swelling index indicates its 
tendency to absorb extrudates from wound. the swelling index 
is calculated by placing 1gm of emulgel on porous aluminum 
foil and then it was placed in petridish containing 10 ml 0.1 N 
Sodium Hydroxide. Then samples were removed from dish at 
different time intervals and put it on dry place for some time 
after it reweighed. Swelling index was calculated using 
formula.  
Swelling Index (SW) % = [(Wt-Wo)/Wo] ×100  
Where (SW) % = Equilibrium percent swelling,  
Wt = Weight of swollen emulgel after time t,  
Wo = Original weight of emulgel at zero time 
Photomicroscopy[37] 
 Emulgel was viewed under light microscope to study the 
globular structure in gel base. The emulgel was suitably 
diluted, mounted on glass slide and viewed by light 
microscope under magnification of 40x 
Dilution test [4] 
50 to 100 times aqueous dilution of emulgel was done by 
adding Continuous phase and visually checked for phase 
separation and clearity.  
Drug content 
One gram of emulgel is mixed with the suitable solvent, 
sonicated and filtered with whatman filter paper no. 41 to 
obtain the clear solution. Absorbance of the solution after 
proper dilution is determined using UV spectrophotometer. 
Standard plot of drug is prepared in the same solvent. 
Concentration and drug content can be determined by using 
the same standard plot by putting the value of absorbance in 
the standard equation [38].  
Drug Content = (Concentration × Dilution Factor × Volume 
taken) × Conversion Factor. 
Globule size and its distribution in emulgels 
Globule size and distribution was determined by Malvern 
zetasizer. A 1.0 gm sample was dissolved in purified water 
and agitated to get homogeneous dispersion. Sample was 
injected to photocell of zetasizer. Mean globule diameter and 
distribution was obtained. Or it is determined by motic 
microscope where the same sample is added on slide and 
observes under microscope [39]. 
Zeta potential  
Zeta Potential of emulsions is determined by Zetatrac, 
measuring the response of charged particles to an electric 
field. In a constant electric field particles drift at a constant 
velocity. Through the velocity, the charge and Zeta Potential 
are determined. Zetatrac utilizes a high frequency AC electric 
field to oscillate the charged particles. The Brownian motion 
power spectrum is analyzed with the Nanotrac controlled 
reference technique of particle sizing to determine the 
Modulated Power Spectrum, a component of the power 
spectrum resulting from the oscillating particles. Zeta 
Potential is calculated from the MPS signal [37].  
In vitro drug release study  
Franz diffusion cell (with effective diffusion area 3 cm2and 30 
ml cell volume) was used for the drug release studies. Emulgel 
(500 mg) was applied onto the surface of cellophane 
membrane evenly. The membrane was clamped between the 
donor and the receptor chamber of diffusion cell. The receptor 
chamber was filled with freshly prepared buffer pH 5.8 
solutions to solublize the drug. The receptor chamber was 
stirred by magnetic stirrer at 50 rpm and maintained  at 
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37±0.2
ᴏ
C  . The samples (1.0 ml aliquots) were collected at 
suitable time interval. Samples were analyzed for drug content 
by UV visible spectrophotometer at 260 nm after appropriate 
dilutions. Cumulative amount of drug released across the 
membrane was determined as the function of time [39]. 
 
Fig 3: Franz vertical diffusion cell 
Skin irritation test 
Few portion of rat was shaved for the application of emulgel 
and an area of 4 cm2 was marked, emulgel was applied (500 
mg) two times a day for 7 days and the site was observed for 
any sensitivity and reaction. The sensitivity was graded as 0, 
1, 2, and 3, for no reaction, slight patchy erythema, patchy 
erythema and severe erythema with or without edema, 
respectively. If the skin irritation symptom arises then the test 
was repeated in more than 2 rats [38]. 
Ex vivo drug release study  
The ex vivo drug release study is carried out in a modified 
Franz diffusion cell. A section of skin was cut from the male 
rat and placed in the space between the donor and receptor 
compartment of the Franz diffusion cell, keeping the dorsal 
side upward. Phosphate buffer pH 7.4 was used as dissolution 
media. The temperature of the cell was maintained constant at 
37±0.2
ᴏ
C by circulating water jacket. This whole assembly 
was kept on a magnetic stirrer and the solution was stirred 
continuously using a magnetic bead. The samples were 
withdrawn at proper time intervals and replaced with same 
amounts of fresh dissolution media. Samples were analyzed by 
proper dilution under UVspectrophotometre [40]. 
Microbiological assay  
 29.5gm of sabouraud dextrose agar was transferred in a 500 
ml of conical flask and 500 ml of purified water and heat is 
applied to dissolve completely. Sterilization was done for 15 
min at 121°C at 15 lb pressure in autoclave. Then the bacterial 
strain or fungus was dispersed in the medium as per the 
requirement of the test after cooling it to room temperature. 
And then the medium was poured it into the three petridish 
and cooled for sometime at room temperature until it forms 
solidifies at room temperature and then the three cups are 
bored in each petridish with the help of sterile steel bore of 6 
mm and calculated concentration of the standard drug, 
emulgel formulation and emulgel without drug were placed in 
the bores with help of 18 gauges needles and incubated the 
petri plates for 18 h at 37°C in incubators. Then the radius 
zone of inhibition was observed and calculated [39]. 
Kinetic analysis of the drug release 
Kinetic analysis of the data was carried out to determine the 
release model which describes 
the proper order of drug release as follow: Zero order 
(cumulative% drug release vs. time, 
first order (log cumulative % drug retained vs. time), and 
Higuchi model (cumulative % drug 
retained vs. square root of time) [41]. 
Stability studies  
Stability test were performed for the optimized formulation; 
the formulations were packed in aluminum collapsible tubes 
and studies were carried out for 3 months as per ICH 
guidelines by keeping at 25 + 2
o
C / 60 + 5% RH and 40 + 2
o
C 
/75 + 5% RH and Samples were withdrawn on at a regular 
interval of 1, 2 & 3 months for evaluation of physical 
appearance, pH, rheological properties, drug content and drug 
release [42]. 
Marketed Emulgels  
The preparations of emulgel that are market commercially are 
listed below in table 1.  
 
Table 1: Marketed emulgels 
Sr.No. Brand name Active ingredient  Manufacturer Uses 
1. Voltarol 1.16% 
emulgel
 
 Diclofenac Diethylammonium 
salt  
Novartis Antiinflamatory 
2. DiclomaxEmulgel
 
Diclofenac sodium Torrent pharma  Antiinflamatory 
3. Miconaz-H-emulgel
 
Miconazole nitrate, 
Hydrocortisone 
Medical union 
Pharmaceuticals 
Topical corticosteroid and 
antifungal 
4. Dermafeet 
Emulgel  
Urea 40% Herbitas Intense moisturizing and 
exfoliation activity  
5. Denacine emulgel Clindamycin phosphate Beit jala pharmaceutical 
company 
Antiacne 
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6. Isofen emulgel Ibuprofen  Beit jala pharmaceutical 
company 
Anti-inflammatory 
7. Diclona emulgel Diclofenac diethylamine Kuwait Saudi pharmaceutical 
industries co. 
Anti-inflammatory 
8. Dosanac emulsion gel Diclofenac diethylammonium Siam bheasach Anti-inflammatory 
9. Diclon emulgel Diclofenac diethylamine medpharma Anti-inflammatory 
10. Cataflam emulgel Diclofenac potassium Novartis  Anti-inflammatory 
 
Conclusion 
Recently most of the new drug molecules are hydrophobic in 
nature, and difficulty has been raised to researcher for the 
delivery of such drug in any form of dosage, because of their 
limited solubility. There has been always a challenging task 
for the formulation of such drugs; here the focus is given for 
the hydrophobic drug that needs to deliver topically. When we 
consider delivering these drugs in conventional dosage form 
as cream, ointment, lotions, emulsion the problem of stability 
and bioavailability rises due to their hydrophobic nature. In 
gel also it is almost negative result to deliver hydrophobic 
drugs.   so the new concept of formulation emulsion in gel has 
shown better delivery as here the drug are incorporated in oil 
phase of emulsion and emulsion is better stabilize in the gel 
and  the combination of both of the phase provide  the 
controlled release effect, that improves the bioavailability of 
that drugs. Such advantages of emulgel provide the big scope 
in future for the delivery of hydrophobic drug topically with 
more efficacy and less production cost. Oils with medicinal 
value provide the Synergistic effect to emulgel.  
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